OZDEMIR, R. Et Al. 2006. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. TOXICOLOGY , vol.219 , 142-149.

OZDEMIR, R., PARLAKPINAR, H., POLAT, A., Colak, C., ERMIS, N., & ACET, A., (2006). Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. TOXICOLOGY , vol.219, 142-149.

OZDEMIR, RAMAZAN Et Al. "Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury," TOXICOLOGY , vol.219, 142-149, 2006

OZDEMIR, RAMAZAN Et Al. "Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury." TOXICOLOGY , vol.219, pp.142-149, 2006

OZDEMIR, R. Et Al. (2006) . "Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury." TOXICOLOGY , vol.219, pp.142-149.

@article{article, author={RAMAZAN OZDEMIR Et Al. }, title={Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury}, journal={TOXICOLOGY}, year=2006, pages={142-149} }